Avicanna Vice President of Medical Affairs Dr. Karolina Urban joins Natalie Stoberman from the Proactive studio to share details behind the company's research on cannabinoid treatment for epilepsy. Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based cannabinoid-based products for the global medical and pharmaceutical market segments.
Avicanna details latest research on cannabinoid epilepsy treatment
